CJ-1639: A potent and highly selective dopamine D3 receptor full agonist

Jianyong Chen, Gregory T. Collins, Beth Levant, James Woods, Jeffrey R. Deschamps, Shaomeng Wang

Producción científica: Articlerevisión exhaustiva

21 Citas (Scopus)

Resumen

We have identified several ligands with high binding affinities to the dopamine D3 receptor and excellent selectivity over the D2 and D1 receptors. CJ-1639 (17) binds to the D3 receptor with a K i value of 0.50 nM and displays a selectivity of >5000 times over D2 and D1 receptors in binding assays using dopamine receptors expressed in the native rat brain tissues. CJ-1639 binds to human D3 receptor with a K i value of 3.61 nM and displays over >1000-fold selectivity over human D1 and D2 receptors. CJ-1639 is active at 0.01 mg/kg at the dopamine D3 receptor in the rat and only starts to show a modest D2 activity at doses as high as 10 mg/kg. CJ-1639 is the most potent and selective D3 full agonist reported to date.

Idioma originalEnglish (US)
Páginas (desde-hasta)620-625
Número de páginas6
PublicaciónACS Medicinal Chemistry Letters
Volumen2
N.º8
DOI
EstadoPublished - ago 11 2011
Publicado de forma externa

ASJC Scopus subject areas

  • Drug Discovery
  • Biochemistry
  • Organic Chemistry

Huella

Profundice en los temas de investigación de 'CJ-1639: A potent and highly selective dopamine D3 receptor full agonist'. En conjunto forman una huella única.

Citar esto